• A Study Using [AL[18F]F]FAPI-74 PET Scan to Improve Diagnosis and Monitoring of Giant Cell Arteritis in Patients with This Blood Vessel Disease

    Recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium
  • Long-term Safety Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease and History of Exacerbations

    Recruiting

    3 1 1
    Investigated Diseases:
    France
  • Testing a Drug Combination with Fluorouracil, Irinotecan, Oxaliplatin, and Folinic Acid Plus Radiation Therapy for Patients with Advanced Rectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    The Netherlands
  • A study of DT-7012 alone and in combination with pembrolizumab in patients with advanced solid tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    France
  • Comparing morphine alone to morphine and lidocaine for pain relief in sickle cell anemia patients with vaso-occlusive crisis

    Recruiting

    3 1 1 1
    Belgium
  • A study testing the safety and effectiveness of inhaled hypochlorous acid in patients with chronic airway infections

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • A Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress

    Recruiting

    2 1
    Bulgaria Czechia Germany Hungary Poland Romania +1
  • A Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia France +10
  • A study of navenibart for long-term safety in patients with hereditary angioedema

    Recruiting

    3 1
    Investigated Drugs:
    Austria Bulgaria Czechia France Germany Hungary +5
  • Study of ONC206 for children and young adults with newly diagnosed or recurrent diffuse midline glioma and other recurrent brain tumors

    Recruiting

    1 1 1
    The Netherlands

powered by